You Searched For "zepbound" and got 20 results
Sort By:
Weight loss and diabetes drug Tirzepatide will cost Rs 80,000 per month in India
Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…
Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …
Hilary Brueck
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a r…
George Glover
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
"Demand continues to outstrip even increased supply," Eli Lilly's CFO said of its Zepbound weight l…
Matthew Fox
People lost nearly 50 pounds on Zepbound — but gained more than half back when they stopped taking it
Zepbound can help people lose significant amounts of weight, but may need to be taken long-term to …
Gabby Landsverk
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar indu…
Gabby Landsverk
Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question
People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…
Hilary Brueck
Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs
Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…
Gabby Landsverk
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…
Matthew Fox
A doctor shares how his patients are trying to afford weight-loss drugs — and what happens if they can't
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients …
Gabby Landsverk
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look fo…
Gabby Landsverk
A man rapidly lost weight on a popular weight-loss drug. After 6 months, he was hospitalized with heart problems and confusion.
A man lost more than 80 pounds in six months on popular weight drug tirzepatide. He hadn't adjusted…
Gabby Landsverk
The next big market for weight-loss drugs: children
Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass ind…
Shubhangi Goel
People who use weight loss drugs like Ozempic face a problem: What to do when they run out or can't take them anymore
Patients sometimes have to stop using GLP-1 medications like Ozempic and Wegovy and risk regaining …
Alex Bitter
A millennial couldn't afford the Mounjaro weight-loss drug so he started secretly working 2 remote jobs. He's on track to make $166,000 this year and says he's lost 45 pounds.
A California-based millennial started secretly working two remote jobs to pay for Mounjaro weight-l…
Jacob Zinkula
Kourtney Kardashian just launched her own take on Ozempic
Kourtney Kardashian's new supplement, Lemme GLP-1 Daily, is marketed as a natural alternative to Oz…
Kim Schewitz
A new Ozempic rival helps patients lose fat, but keep their muscle the holy grail for a weight-loss drug
The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial,…
Hilary Brueck
Insider Today: Austin's genius housing fix
In this Saturday version of Insider Today, we're talking about Austin, Texas' real estate cycle and…
Joi-Marie McKenzie
Weight-loss drugs just got cheaper and better
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual mov…
Shelby Livingston,Hilary Brue…
Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion
"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…